Free shipping on all orders over $ 500

SKI II

Cat. No. M3012

All AbMole products are for research use only, cannot be used for human consumption.

SKI II Structure
Synonym:

SphK-I2

Size Price Availability Quantity
5mg USD 40 In stock
10mg USD 50 In stock
25mg USD 75 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

SKI II is a highly selective and oral active inhibitor of sphingosine kinase (SK) activity, with IC50 values of 78 μM and 45 μM for SK1 and for SK2, while exhibits no inhibitory on other kinases including PI3K, PKCα and ERK2.

Protocol (for reference only)
Cell Experiment
Cell lines T-24, MCF-7, MCF-7/VP, NCI/ADR cell lines
Preparation method T24, MCF-7, MCF-7/VP, and NCI/ADR cells are plated into 96-well tissue culture plates at ~15% confluency. 24 hours Later, treating the cells are with various concentrations of inhibitors. An additional 48 hours later , cell survival is assayed using the sulforhodamine B assay
Concentrations ~50 μM
Incubation time 48 hours
Animal Experiment
Animal models JC xenografts are established in mice
Formulation DMSO (ip), polyethylene glycol 400 (oral)
Dosages ~100 mg/kg
Administration Intraperitoneal administration or oral administration
Chemical Information
Molecular Weight 302.78
Formula C15H11ClN2OS
CAS Number 312636-16-1
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Dhananjay Kumar Sah, et al. Sphingosine kinase inhibitor, SKI-II confers protection against the ionizing radiation by maintaining redox homeostasis most likely through Nrf2 signaling

[2] Corentin Claeys Bouuaert, et al. Structural and functional characterization of the Spo11 core complex

[3] Michael Hasler, et al. On the measurement of ski boot viscoelasticity

[4] Li Yang, et al. SphK1 inhibitor II (SKI-II) inhibits acute myelogenous leukemia cell growth in vitro and in vivo

[5] Ying Liu, et al. SKI-II reverses the chemoresistance of SGC7901/DDP gastric cancer cells

Related S1P Receptor Products
FTY720 hydrochloride

Fingolimod (FTY720) HCl is a 1-phospho-neuraminol S1P receptor antagonist with an IC50 of 0.33 nM. , FTY720 can dephosphorylate AMPK by activating PP2A and reduce the expression level of phosphorylated eEF2K, ultimately leading to ADCD and iron death in human multiple myeloma cells.

BAF312

BAF312 (Siponimod) is a next-generation S1P receptor modulator, selective for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, exhibits >1000-fold selectivity over S1P2, S1P3 and S1P4 receptors.

SEW2871

SEW2871 is an orally active, potent, highly selective S1P1 (sphingosine-1-phosphate type 1 receptor) agonist, with an EC50 of 13.8 nM. SEW2871 activates ERK, Akt, and Rac signaling pathways and induces S1P1 internalization and recycling.

CYM-5442

CYM-5442 is a potent and selective S1P1 agonist with EC50 of 1.35 nM. CYM5442 activates S1P1-dependent p42/p44-MAPK phosphorylation. CYM5442 can easily penetrate the central nervous system (CNS).

JTE 013

JTE 013 is a potent and selective S1P2 antagonist with IC50 of 17.6 nM.

  Catalog
Abmole Inhibitor Catalog




Keywords: SKI II, SphK-I2 supplier, S1P Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.